Activation of murine peritoneal macrophages by Streptococcus pneumoniae type II capsular polysaccharide: Involvement of CD14-dependent pathway

Scandinavian Journal of Immunology

Volumn 52, Issue 1, 2000, Pages 39-45

  Um, S H ^a   Son, E W ^a   Kim, B O ^a   Moon, E Y ^a   Rhee, D K ^a   Pyo, S ^a  

^a Sungkyunkwan University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL POLYSACCHARIDE; BINDING PROTEIN; CD14 ANTIGEN; INTERFERON ANTIBODY; LEUKOCYTE ANTIBODY; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; SCAVENGER; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ANIMAL CELL; ANTIGEN BINDING; ARTICLE; CELL ACTIVITY; CELL SECRETION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVITY; MACROPHAGE ACTIVATION; MALE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; STREPTOCOCCUS PNEUMONIAE; TUMOR CELL DESTRUCTION;

ANIMALS; ANTIGENS, CD14; BACTERIAL CAPSULES; MACROPHAGE ACTIVATION; MACROPHAGES, PERITONEAL; MALE; MICE; MICE, INBRED C57BL; NITRIC OXIDE; POLYSACCHARIDES, BACTERIAL; STREPTOCOCCUS PNEUMONIAE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033934735     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.2000.00749.x     Document Type: Article

References (43)

1. 1 Barry MG, Coverse III GM, Dillion HC Jr. Epidemiologic studies of Streptococcus pneumoniae in infants: acquisition, carriage, and infection during the first 24 months of life. J Infect Dis 1980;142:923-33.
2. 2 Boulnois GJ. Pneumococcal proteins and the pathogenesis of disease caused by Streptococcus pneumoniae. J Gen Microbiol 1992;138:249-59.
3. 3 Mason EO, Kaplan SL, Lamberth LB, Tillman J. Increased rate of isolation of penicillin-resistant Streptococcus pneumoniae in a children's hospital and in vitro susceptibilities to antibiotics of potential therapeutic use. Antimicrob Agents Chemother 1992;36:1703-7.
4. 4 Kasper DL. Bacterial capsule-old dogmas and new tricks. J Infect Dis 1986;153:407-15.
5. 5 Simpson S, Singh QR, Bice DE. Heat-killed pneumococci and pneumococcal capsular polysaccharides stimulate tumour necrosis factor-α production by murine macrophages. Am J Respir Cell Mol Biol 1994;10:284-98.
6. 6 Tuomanen E, Rich R, Zak O. Induction of pulmonary inflammation by components of the pneumococcal cell surface. Am Rev Respir Dis 1987;135:869-74.
7. 7 Garg M, Kaplan AM, Bondada S. Cellular basis of differential responsiveness of lymph nodes and spleen to 23-valent Pnu-Immne vaccine. J Immunol 1994;152:1589-96.
8. 8 Goud SN, Muthusamy N, Subbarao B. Differential responses of B cells from the spleen and lymph node to TNP-Ficoll. J Immunol 1988;140:2925-31.
9. 9 Hahn H, Kaufmann SHE. The role of cell-mediated immunity in bacterial infections. Rev Infect Dis 1981;3:1221-50.
10. 10 Verstovsek S, Maccubbin D, Mihich E. Tumouricidal activation of murine resident peritoneal macrohage by interleukin-2 and tumour necrosis factor. Cancer Res 1992;52:3880-5.
11. 11 Dullens HFJ, De Weger RA, Van Der Maas M, Den Besten PJ, Vandebriel RJ, Den Otter W. Production of specific macrophage-arming factor precedes cytotoxic T-lymphocyte activity in vivo during tumour rejection. Cancer Immunol Immunother 1989;30:28-33.
12. 12 Gautam S, Deodhar S. Generation of tumoricidal effector cells by human C-reactive protein and muramyl tripeptide: a comparative study. J Biol Res Modif 1989;8:560-9.
13. 13 Paulnock DM, Lambert LE. Identification and characterization of monoclonal antibodies specific for macrophages at intermediate stages in the tumouricidal activation pathway. J Immunol 1988;144:765-73.
14. 14 Arden L, Lansdorp P, De Groot E. A growth factor for B-cell hybridomas produced by human moncytes. Lymphokines 1985;10:175-85.
15. 15 Arenzana-Seisdedos F, Virelizier J. Interferons as macrophage-activating factors. II. Enhanced secretion of interleukin-1 by lipopolysaccharide-stimulated human moncytes. Eur J Immunol 1983;13:437-40.
16. 16 Choriki M, Freudenberg M, Calanos C, Poindron P, Bartholeyns J. Antitumoural effects of lipopolisacchride, tumour necrosis factor, interferon and activated macrophages: synergism and tissue distribution. Anticancer Res 1989;9:1185-90.
17. 17 Stuehr DJ, Marletta MA. Synthesis of nitrite and nitrate in macrophage cell lines. Cancer Res 1987;47:5590-4.
18. 18 Keller R, Keist R, Frei K. Lymphokines and bacteria that induce tumouricidal activity, trigger a different secretory response in macropahges. Eur J Immunol 1990;20:695-8.
19. 19 Orman KL, Shenep JL, English BK. Pneumococci stimulate the production of the inducible nitric oxide synthase and nitric oxide by murine macrophages. J Infect Dis 1998;178:1649-57.
20. 20 Haziot A, Chen S, Ferrero E, Low MG, Silber R, Goyert SM. The monoxyte differentiation antigen, CD14, is anchored to the cell membrane by a phosphatidylinositol linkage. J Immunol 1988;141:547-52.
21. 21 Simmons DL, Tan S, Tenen DG, Nichloson-Weller A, Seed B. Monocyte antigen CD14 is a phospholipid anchored membrane protein. Blood 1989;73:284-9.
22. 22 Wright SD, Ramons RA, Tobias PS, Ulevitch RJ, Mathison JC. CD14, a receptor for complexs of lipopolysaccharide (LPS) and LPS-binding protein. Science 1990;249:1431-3.
23. 23 Dentener M, Bazil V, Von Asmuth EJU, Ceska M, Buurman WA. Involvement of CD14 in lipopolysaccharide-induced tumour necrosis factor-α, IL-6 and IL-8 release by human monocytes and alveolar macrophages. J Immunol 1993;150:2885-91.
24. 24 Klimetzek V, Remold HD. The murine bone marrow macrophage, a sensitive indicator cell for murine migration inhibitory factor and a new method for their harvest. Cell Immunol 1980;53:257-66.
25. 25 von Hunolstein C, D'Ascenzi S, Wagner B et al. Immunochemistry of the type capsular polysaccharide and virulence proerties of type VI Streptococcus agalactiae (group B streptococcus). Infect Immun 1993;61:1272-80.
26. 26 White CA, Kennedy JF. Oligosaccharides. In: Carbohydrate Analysis: a Practical Approach (Chaplin MF, Kennedy JF. eds). Oxford: IRL Press, 1986:37-8.
27. 27 Ding AH, Nathan CF, Stuer DJ. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J Immunol 1988;141:2407-12.
28. 28 Flick DA, Gifford GE. Comparison of in vitro cell cytotoxicity assays for tumour necrosis factor. J Immunol 1984;68:167-75.
29. 29 Vodovotz Y, Bogdan C, Paik J, Xie QW, Nathan C. Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor-B. J Exp Med 1993;178:605-13.
30. 30 Decker T, Lohmann-Mathes ML, Gifford G. Cell-associated tumour necrosis factor as a killing mechanism of activated cytotoxic macrophages. J Immunol 1987;130:957-62.
31. 31 Mavier P, Edgington TS. Human monocyte-mediated tumour cytotoxicity. I. Demonstration of an oxygen dependent myeloperoxidase-independent mechanism. J Immunol 1984;132:1980-4.
32. 32 Hibbs JB, Taintor RR, Vavrin Z. Macrophage cytotoxicity: role for L-arginine deiminase and imino-nitrogen oxidation to nitrite. Science 1987;235:473-6.
33. 33 Remels L, Fransen L, Huygen K, De Baetselier P, Poly I. C-activated macrophages are tumouricidal for TNF-alpha-resistant 3LL tumor cells. J Immunol 1990;144:4477-86.
34. 34 Cauwels AE, Leismann WM, Tuomanen E. Coexistence of CD14-dependent and independent pathways for stimulation of human monocytes by Gram-positive bacteria. Infect Immun 1997;65:3255-60.
35. 35 Cleveland MG, Gorham JD, Murphy TL, Tuomanen E, Murphy KM. Lipoteichoic acid preparations of Gram-positive bacteria induce interleukin-12 through a CD14-dependent pathway. Infect Immun 1996;64:1906-12.
36. 36 Kusunoki T, Wright SD. Chemical characteristics of Staphylococcus aureus molecules that have CD14-dependent cell-stimulating activity. J Immunol 1996;157:5112-7.
37. 37 Riesenfeld-Orn I, Wolpe S, Garcia-Bustos JF, Hoffmann MK, Tuomanen E. Production of interleukin-1 but not tumour necrosis factor by human monocytes stimuated with pneumococcal cell surface components. Infect Immun 1989;57:1890-3.
38. 38 Bhakdi S, Klonisch T, Nuber P, Fischer W. Stimulation of monokine production by lipoteichoic acids. Infect Immun 1991;59:4614-20.
39. 39 Keller R, fischer W, Keist R, Bassetti S. Macrophage response to bacteria: induction of marked secretory and cellular activities by lipoteichoic acids. Infect Immun 1992;60:3664-72.
40. 40 Sharon N, Shoham J, Passwell JH. Enhancement of human monocyte cytotoxicity by both interferon-γ and -β and comparison to other stimuli. Int J Immunopharmac 1989;11:743-9.
41. 41 Higuchi M, Higashi N, Taki H, Osawa T. Cytolytic mechanisms of activated macrophages: tumour necrosis factor and L-arginine-dependent mechanisms act synergistically as the major cytotolytic mechanisms of activated macrophages. J Immunol 1990;144:1425-31.
42. 42 Klostergaard J, Leroux ME, Hung M. Cellular models of macrophage tumouricidal effector mechanisms in vitro. J Immmunol 1991;147:2802-8.
43. 43 Haziot A, Hijiya N, Schultz K, Zhang F, Gangloff S, Goyert S. CD14 plays no major role in shock induced by Staphylococcus aureus but down-regulates TNF-α production. J Immunol 1999;162:4801-5.